Hindustan Laboratories Taps Capital Markets, Files IPO Papers with SEBI
The company proposes to utilize IPO proceeds for funding the working capital requirements and general corporate purposes.
Written By : sheeba farhat
Published On 2026-01-05 12:00 GMT | Update On 2026-01-05 12:00 GMT
Advertisement
New Delhi: Generic drug maker Hindustan Laboratories has filed preliminary papers with capital markets regulator Sebi to raise funds through an initial public offering (IPO).
The company's maiden public offering comprises a fresh issue of 50 lakh shares along with an Offer for sale (OFS) of 91 lakh shares by the promoter, according to the draft red herring prospectus (DRHP).
The company proposes to utilize IPO proceeds for funding the working capital requirements and general corporate purposes.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.